10.43
P 3 Health Partners Inc stock is traded at $10.43, with a volume of 34,962.
It is down -2.39% in the last 24 hours and down -3.60% over the past month.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
See More
Previous Close:
$10.69
Open:
$10.7
24h Volume:
34,962
Relative Volume:
0.03
Market Cap:
$40.27M
Revenue:
$1.47B
Net Income/Loss:
$-275.80M
P/E Ratio:
-0.2702
EPS:
-38.5968
Net Cash Flow:
$-85.24M
1W Performance:
-18.71%
1M Performance:
-3.60%
6M Performance:
+389.67%
1Y Performance:
+53.95%
P 3 Health Partners Inc Stock (PIII) Company Profile
Name
P 3 Health Partners Inc
Sector
Industry
Phone
312-822-8897
Address
2045 W GRAND AVE STE B, CHICAGO
Compare PIII vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PIII
P 3 Health Partners Inc
|
10.29 | 41.80M | 1.47B | -275.80M | -85.24M | -38.60 |
|
HCA
Hca Healthcare Inc
|
406.02 | 87.61B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
265.31 | 21.57B | 21.46B | 2.65B | 3.35B | 19.23 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.53 | 12.65B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
121.88 | 12.19B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
DVA
Davita Inc
|
176.59 | 11.49B | 13.84B | 1.10B | 1.49B | 10.42 |
P 3 Health Partners Inc Stock (PIII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-25 | Resumed | Lake Street | Buy |
| Apr-01-24 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-01-23 | Initiated | BTIG Research | Buy |
| Jun-30-23 | Initiated | TD Cowen | Market Perform |
P 3 Health Partners Inc Stock (PIII) Latest News
P3 Health Partners Signals Turnaround in Earnings Call - TipRanks
TD Cowen Maintains P3 Health Partners(PIII.US) With Hold Rating, Maintains Target Price $13 - Moomoo
US$18.00That's What Analysts Think P3 Health Partners Inc. (NASDAQ:PIII) Is Worth After These Results - simplywall.st
TD Cowen Maintains P3 Health Partners(PIII.US) With Hold Rating, Cuts Target Price to $13 - Moomoo
Hudson Vegas Investment SPV Completely Divests P3 Health Partners Shares - Kalkine Media
Hudson Vegas Investment Spv, L Sells 50,000 Shares of P3 Health Partners (NASDAQ:PIII) Stock - MarketBeat
P3 Health Partners (PIII) holder Hudson Vegas updates 17.5% stake and recent share sales - Stock Titan
P3 Health Partners Inc.Class A Common Stock (NQ: PIII - FinancialContent
P3 Health Partners price target raised to $23 from $14 at Lake Street - TipRanks
PIII|P3 Health Partners Inc|Price:12.870|Chg%:+1.290 - TradingKey
P3 Health Partners earnings beat by $1.38, revenue topped estimates - Investing.com Canada
P3 Health Partners Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
P3 Health Partners Q2 Earnings Call Highlights - MarketBeat
P3 Health Partners narrows FY2026 sales guidance to $1.500B-$1.600B - scanx.trade
P3 Health Partners Q2 EPS beats estimate, revenue tops $386 million - scanx.trade
P3 Health Partners Inc reports results for the quarter ended June 30Earnings Summary - TradingView
P3 Health Partners reports Q2 EPS (63c), consensus ($1.90) - TipRanks
Earnings call transcript: P3 Health Partners posts Q2 2026 beat, raises outlook - Investing.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
P3 Health Partners (NASDAQ:PIII) Posts Earnings Results, Beats Expectations By $1.26 EPS - MarketBeat
P3 Health Partners Inc. 2026: Revenue $386.38M, EPS ($0.63) — 10-Q Summary - TradingView
P3 Health Partners lifts 2026 adjusted EBITDA outlook amid structural improvements - TradingView
P3 Health Partners posts $386M revenue, $54.4M adjusted EBITDA in Q2 2026 - TradingView
P3 Health Partners (PIII) turns Q2 profit as debt converts to preferred stock - Stock Titan
P3 Health reports $15.7M net income, lifts 2026 EBITDA outlook - Stock Titan
P3 Health Partners Q2 2026 Earnings Call Transcript - MarketBeat
P3 Health Partners Stock (PIII) Opinions on Upcoming Earnings Reports - Quiver Quantitative
P3 Health Partners Inc (PIII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Price to earnings forward of P3 Health Partners Inc. – BOATS:PIIIW - TradingView
P3 Health Partners Inc expected to post a loss of $1.89 a shareEarnings Preview - TradingView
Earnings To Watch: P3 Health Partners Inc (PIII) Q2 2026 -- GF V - GuruFocus
Earnings To Watch: P3 Health Partners Inc (PIII) Q2 2026 -- GF Value Sees 48% Downside - Yahoo Finance
P3 Health Partners Inc (PIII) Stock Analysis & Forecast - TradingKey
P3 Health Partners (NASDAQ:PIII) Trading 8.9% HigherHere's Why - MarketBeat
P3 Health Partners Inc (PIII) Income Statement - TradingKey
P3 Health Partners Inc (PIII) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
P3 Health Partners Inc (PIII) Institutional Confidence - TradingKey
P3 Health Partners Inc. Revenue Breakdown – NASDAQ:PIIIW - TradingView
P3 Health Partners Inc (PIII) Cash Flow - TradingKey
P3 Health Partners Inc (PIII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
P3 Health Partners Inc (PIII) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
P3 Health Partners Inc (PIII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PIII|P3 Health Partners Inc|Price:10.530|Chg%:+0.910 - TradingKey
P3 Health Partners Inc (PIII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
P3 Health Partners Inc (PIII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), UnitedHealth (UNH) and AnaptysBio (ANAB) - The Globe and Mail
P3 Health Partners(PIII) Stock Options Chain | Quotes & News - Moomoo
P3 Health Partners (PIII) Stages Modest Advance, Testing Key Resistance at $10.78Monthly Profile - dars.gov.et
U.S. Physical Therapy, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call Dates - Yahoo Finance
P3 Health Partners announces Q2 2026 earnings date - scanx.trade
Press Release: P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call - Moomoo
P 3 Health Partners Inc Stock (PIII) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):